Lotus Bio-Technology Development Corp
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $0.01
- Today's High:
- $0.01
- Open Price:
- $0.01
- 52W Low:
- $0.001
- 52W High:
- $0.08
- Prev. Close:
- $0.01
- Volume:
- 0
Company Statistics
- Market Cap.:
- $11.74 million
- Book Value:
- 0
- Revenue TTM:
- $0
- Operating Margin TTM:
- 0%
- Gross Profit TTM:
- $0
- Profit Margin:
- 0%
- Return on Assets TTM:
- -421.3%
- Return on Equity TTM:
- 0%
Company Profile
Lotus Bio-Technology Development Corp had its IPO on under the ticker symbol LBTD.
The company operates in the Basic Materials sector and Agricultural Inputs industry. Lotus Bio-Technology Development Corp has a staff strength of 0 employees.
Stock update
Shares of Lotus Bio-Technology Development Corp opened at $0.01 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $0.01 - $0.01, and closed at $0.01.
This is a 0% increase from the previous day's closing price.
A total volume of 0 shares were traded at the close of the day’s session.
In the last one week, shares of Lotus Bio-Technology Development Corp have increased by 0%.
Lotus Bio-Technology Development Corp's Key Ratios
Lotus Bio-Technology Development Corp has a market cap of $11.74 million, indicating a price to book ratio of 0 and a price to sales ratio of 0.
In the last 12-months Lotus Bio-Technology Development Corp’s revenue was $0 with a gross profit of $0 and an EBITDA of $0. The EBITDA ratio measures Lotus Bio-Technology Development Corp's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Lotus Bio-Technology Development Corp’s operating margin was 0% while its return on assets stood at -421.3% with a return of equity of 0%.
In Q4, Lotus Bio-Technology Development Corp’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.
Lotus Bio-Technology Development Corp’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
- 0
Its diluted EPS in the last 12-months stands at $0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Lotus Bio-Technology Development Corp’s profitability.
Lotus Bio-Technology Development Corp stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -40.1416. Its price to sales ratio in the trailing 12-months stood at 0.
Lotus Bio-Technology Development Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $55463.00
- Total Liabilities
- $66771.00
- Operating Cash Flow
- $0
- Capital Expenditure
- $0
- Dividend Payout Ratio
- 0%
Lotus Bio-Technology Development Corp ended 2024 with $55463.00 in total assets and $0 in total liabilities. Its intangible assets were valued at $55463.00 while shareholder equity stood at $-61308.00.
Lotus Bio-Technology Development Corp ended 2024 with $0 in deferred long-term liabilities, $66771.00 in other current liabilities, 828.00 in common stock, $-929399.00 in retained earnings and $0 in goodwill. Its cash balance stood at $50005.00 and cash and short-term investments were $50005.00. The company’s total short-term debt was $0 while long-term debt stood at $0.
Lotus Bio-Technology Development Corp’s total current assets stands at $50005.00 while long-term investments were $0 and short-term investments were $0. Its net receivables were $0 compared to accounts payable of $15313.00 and inventory worth $0.
In 2024, Lotus Bio-Technology Development Corp's operating cash flow was $0 while its capital expenditure stood at $0.
Comparatively, Lotus Bio-Technology Development Corp paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $0.01
- 52-Week High
- $0.08
- 52-Week Low
- $0.001
- Analyst Target Price
- $
Lotus Bio-Technology Development Corp stock is currently trading at $0.01 per share. It touched a 52-week high of $0.08 and a 52-week low of $0.08. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $0.01 and 200-day moving average was $0.01 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 6040.4% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Lotus Bio-Technology Development Corp
Similar Industry Stocks (Agricultural Inputs)
Most Active
Top Gainers
Top Losers
About
Lotus Bio-Technology Development Corp., a bio-technology development company, focuses on refining organic materials, and production of natural consumer related products in China. The company was formerly known as Starflick.com and changed its name to Lotus Bio-Technology Development Corp. in April 2016. Lotus Bio-Technology Development Corp. was founded in 2011 and is based in Cave Creek, Arizona.